Apixaban-Calibrated Anti-FXa Activity in Relation to Outcome Events and Clinical Characteristics in Patients with Atrial Fibrillation: Results from the AVERROES Trial
- DOI
- 10.1055/s-0037-1613679
- Published
- 2017-07
- Container
- TH Open
- Publisher
- Georg Thieme Verlag KG
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1055/s-0037-1613679,
title = {Apixaban-Calibrated Anti-FXa Activity in Relation to Outcome Events and Clinical Characteristics in Patients with Atrial Fibrillation: Results from the AVERROES Trial},
author = {Vinai Bhagirath and John Eikelboom and Jack Hirsh and Michiel Coppens and Jeffrey Ginsberg and Thomas Vanassche and Fei Yuan and Noel Chan and Salim Yusuf and Stuart Connolly},
year = {2017},
journal = {TH Open},
doi = {10.1055/s-0037-1613679},
url = {https://doi.org/10.1055/s-0037-1613679}
}RIS
TY - JOUR TI - Apixaban-Calibrated Anti-FXa Activity in Relation to Outcome Events and Clinical Characteristics in Patients with Atrial Fibrillation: Results from the AVERROES Trial AU - Vinai Bhagirath AU - John Eikelboom AU - Jack Hirsh AU - Michiel Coppens AU - Jeffrey Ginsberg AU - Thomas Vanassche AU - Fei Yuan AU - Noel Chan AU - Salim Yusuf AU - Stuart Connolly PY - 2017 JO - TH Open DO - 10.1055/s-0037-1613679 UR - https://doi.org/10.1055/s-0037-1613679 ER -
APA
Bhagirath, V., Eikelboom, J., Hirsh, J., Coppens, M., Ginsberg, J., Vanassche, T., Yuan, F., Chan, N., Yusuf, S., & Connolly, S. (2017). Apixaban-Calibrated Anti-FXa Activity in Relation to Outcome Events and Clinical Characteristics in Patients with Atrial Fibrillation: Results from the AVERROES Trial. TH Open. https://doi.org/10.1055/s-0037-1613679
Source records
- crossref · retrieved 2026-09-25T11:50:54.273Z